Resmed (NYSE:RMD) will report earnings after markets close on Thursday, April 25th. ResMed Inc. develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing. The Company sells diagnostic and treatment devices in various countries through its subsidiaries and independent distributors.
Here is your Cheat Sheet to Resmed Earnings:
Earnings Expectations: Analysts expect earnings of $0.57 per share on revenues of $387.88 million. Currently, the company’s P/E ratio stands at 22.20.
Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.58 to a profit $0.61. For the current year, the average estimate is a profit of $2.24, which is better than the estimate ninety days ago.
Here’s how Resmed has been performing on an annual basis:
|Revenue ($) in millions||835.40||920.74||1,092||1,243||1,369|
|Diluted EPS ($)||0.70||0.95||1.23||1.44||1.71|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||332.74||349.07||371.93||339.73||376.54|
|Diluted EPS ($)||0.42||0.44||0.52||0.49||0.53|
Resmed has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)